CHU de Bordeaux
Bordeaux, 33076, France
NCT Number: NCT03295864
The aim of this study is to compare the value of multifrequency tympanometry between patients with surgical indication of treatment for a Chiari type I malformation and healthy volunteers.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Bordeaux, 33076, France
Prevalence of Chiari type I malformation in population is between 0.1% and 0.5%. Chiari type I malformation is responsive in perturbation of the cerebro spinal fluid flow at the cranio-cervical junction. Those perturbations caused headaches, and various otological symptoms (dizziness, tinnitus, vertigo, nystagmus, hypoacousis…). The surgical treatment consists in an occipital craniotomy to restore the cerebro spinal fluid flow at the cranio-cervical junction. Symptoms are due to increasing of the pressure in the cerebellar fossa. 81% of the patients with Chiari type 1 malformation suffer of sub clinical otological perturbations especially alteration of the vestibular test.
In the literature, hearing performance could be normalized after posterior fossa decompression. Furthermore, the multifrequency tympanometry measurement and particularly the width of conductance tympanograms at 2 kHz shows that variations of the cerebro spinal fluid pressure have consequences on the pressure of the perilymph.
Investigator's hypothesis is that tympanometry (conductance) could be an effective test to show the variation of the cerebro spinal fluid pressure.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for healthy volunteers:
Exclusion criteria
Exclusion criteria
for healthy volunteers:
Multifrequency tympanometry measurement and particularly width of conductance tympanograms at 2 kHz will be performed for both group at inclusion
Multifrequency tympanometry measurement and particularly width of conductance tympanograms at 2 kHz will be performed 6 months after surgery for Chiari type I malformation patient
Time frame: Inclusion
Time frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
Time frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
Time frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
Time frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
Time frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
Time frame: Inclusion and 6 months after surgery for patients with an indication of surgical management for a Chiari type I malformation
University Hospital, Bordeaux
Other
Acronym: MCoto
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02669836
Arnold-Chiari Malformation, Arnold-Chiari Malformation, Type 1
St Louis, Missouri, United States
View Trial DetailsNCT00004738
Arnold-Chiari Malformation, Carbohydrate Metabolism, Inborn Errors
Bethesda, Maryland, United States
View Trial DetailsNCT01150708
Arnold Chiari Deformity, Arnold-Chiari Malformation
Bethesda, Maryland, United States
View Trial DetailsNCT05754554
Arnold-Chiari Malformation, Atlantoaxial Dislocation
Guangzhou, Guangdong, China
View Trial Details